Latest Headlines
A new tuberculosis drug given special status by both U.S. and European regulators might lead to simpler, more effective TB treatment regimens.
The Bill and Melinda Gates Foundation, headquartered in Seattle, has started a $100 million fund for research grants related to global health.
U.S. and Japanese scientists have identified a specific genetic mutation as the cause of a rare immunodeficiency disorder known as Job’s syndrome.
U.S. scientists say the genetic blueprints of more than 2,000 human and avian influenza viruses worldwide have been completed and made public.
U.S. scientists have generated an atomic picture of part of the human immunodeficiency virus in a move that could greatly help AIDS vaccine design.
National Institutes of Health officials say there is now substantial proof male circumcision is effective in limiting transmission of the AIDS virus. The National Institute of Allergy and Infectious Diseases, part of the NIH, said it stopped two African c
A U.S. scientist has created a vaccine that, in a mouse study, significantly protected the animals from various strains of Staphylococcus aureus.
U.S. medical researchers say they've developed a vaccine that protects mice against the killer 1918 influenza virus. The National Institutes of Health scientists say they also have created a technique for identifying antibodies that neutralize that deadly
U.S. scientists have completed the first comprehensive analysis of an animal's immune response to the 1918 influenza virus.
The U.S. National Institute of Allergy and Infectious Diseases has announced five awards totaling $4 million to fund a study of anti-radiation treatments.
